scispace - formally typeset
A

Agnès Fournier

Researcher at Université Paris-Saclay

Publications -  137
Citations -  8381

Agnès Fournier is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Breast cancer & Prospective cohort study. The author has an hindex of 40, co-authored 124 publications receiving 7098 citations. Previous affiliations of Agnès Fournier include University of Oxford & University of Paris-Sud.

Papers
More filters
Journal ArticleDOI

Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Nobuyuki Hamajima, +292 more
- 01 Nov 2012 - 
TL;DR: The effects of menarche and menopause on breast cancer risk might not be acting merely by lengthening women's total number of reproductive years, and endogenous ovarian hormones are more relevant for oestrogen receptor-positive disease than for ostrogens receptor-negative disease and for lobular than for ductal tumours.
Journal ArticleDOI

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

TL;DR: The findings suggest that the choice of the progestagen component in combined HRT is of importance regarding breast cancer risk; it could be preferable to use progesterone or dydrogesterone.
Journal ArticleDOI

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Nobuyuki Hamajima, +294 more
- 29 Aug 2019 - 
TL;DR: Every MHT type, except vaginal oestrogens, was associated with excess breast cancer risks, which increased steadily with duration of use and were greater for oestrogen-progestagen than oest estrogen-only preparations; among current users, these excess risks were definite even during years 1–4.
Journal ArticleDOI

Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)

TL;DR: A case-control study nested within the European Prospective Investigation into Cancer and Nutrition cohort to examine associations among premenopausal serum concentrations of sex steroids and subsequent breast cancer risk found no statistically significant association with serum levels.